{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:06:46Z","timestamp":1790924806461,"version":"4.1.0"},"reference-count":27,"publisher":"AMPCo","issue":"10","license":[{"start":{"date-parts":[[2012,6,4]],"date-time":"2012-06-04T00:00:00Z","timestamp":1338768000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Journal of Australia"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.5694\/mja11.11531","type":"journal-article","created":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T06:27:50Z","timestamp":1339050470000},"page":"629-632","source":"Crossref","is-referenced-by-count":63,"title":["The changing therapeutic landscape for hepatitis C"],"prefix":"10.5694","volume":"196","author":[{"given":"Gregory J","family":"Dore","sequence":"first","affiliation":[{"name":"The Kirby Institute for infection and immunity in society, University of New South Wales, Sydney, NSW."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3677","published-online":{"date-parts":[[2012,6,4]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00651.x"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22375"},{"key":"e_1_2_9_4_1","volume-title":"HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2011","author":"The Kirby Institute","year":"2011"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.05.026"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05910.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02411.x"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.116"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(02)00116-6"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010494"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009482"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012912"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013086"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014463"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24172"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.05.046"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.447"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08309"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283471cae"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir210"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24262"},{"issue":"378","key":"e_1_2_9_22_1","article-title":"SILEN\u2010C3: Treatment for 12 or 24 weeks with BI201335 combined with peginterferon alfa\u20102a and ribavirin (P\/R) in treatment\u2010naive patients with chronic genotype\u20101 HCV infection","volume":"54","author":"Dieterich D","year":"2011","journal-title":"Hepatology"},{"issue":"1429","key":"e_1_2_9_23_1","article-title":"TMC435 in combination with peginterferon and ribavirin in treatment\u2010naive HCV genotype 1 patients: final analysis of the PILLAR phase IIb study","volume":"54","author":"Fried M","year":"2011","journal-title":"Hepatology"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104430"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61384-0"},{"issue":"1428","key":"e_1_2_9_26_1","article-title":"Dual oral combination therapy with the NS5A inhibitor BMS\u2010790052 and the NS3 protease inhibitor BMS\u2010650032 achieved 90% sustained virological response (SVR12) in HCV genotype 1b\u2010infected null responders","volume":"54","author":"Chayama K","year":"2011","journal-title":"Hepatology"},{"issue":"377","key":"e_1_2_9_27_1","article-title":"Once daily PSI\u20107977 plus RBV: pegylated interferon\u2010alfa not required for complete rapid viral response in treatment\u2010naive patients with HCV GT2 or GT3","volume":"54","author":"Gane E","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"e_1_2_9_28_1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1478-3231.2010.02383.x","article-title":"Future hepatitis C virus treatment: interferon\u2010sparing combinations","volume":"31","author":"Gane E","year":"2011","journal-title":"Liver Int"}],"container-title":["Medical Journal of Australia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.5694\/mja11.11531","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.5694\/mja11.11531","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.5694\/mja11.11531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:31:09Z","timestamp":1600648269000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.5694\/mja11.11531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.5694\/mja11.11531"],"URL":"https:\/\/doi.org\/10.5694\/mja11.11531","archive":["Portico"],"relation":{},"ISSN":["0025-729X","1326-5377"],"issn-type":[{"value":"0025-729X","type":"print"},{"value":"1326-5377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}